Cargando…
Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (Schizosaccharomyces pombe)
Successful combination antiretroviral therapies (cART) eliminate active replicating HIV-1, slow down disease progression, and prolong lives. However, cART effectiveness could be compromised by the emergence of viral multidrug resistance, suggesting the need for new drug discoveries. The objective of...
Autores principales: | Zhang, Jiantao, Vernon, Kasey, Li, Qi, Benko, Zsigmond, Amoroso, Anthony, Nasr, Mohamed, Zhao, Richard Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308830/ https://www.ncbi.nlm.nih.gov/pubmed/34202872 http://dx.doi.org/10.3390/pathogens10070804 |
Ejemplares similares
-
HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe
por: Benko, Zsigmond, et al.
Publicado: (2016) -
Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe
por: Nkeze, Joseph, et al.
Publicado: (2015) -
Featured Organism: Schizosaccharomyces pombe, The Fission Yeast
por: Wixon, Jo
Publicado: (2002) -
Population Genomics of the Fission Yeast Schizosaccharomyces pombe
por: Fawcett, Jeffrey A., et al.
Publicado: (2014) -
Response to leucine in Schizosaccharomyces pombe (fission yeast)
por: Ohtsuka, Hokuto, et al.
Publicado: (2022)